IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
RMDL: Classification of Parkinson's disease by nature-inspired Algorithm
Antidiabetic activity (In vitro alpha amylase inhibitory) of ethanol extract of Carissa carandas Linn. roots.
Six sigma: an embellished exploration in the field of pharmaceutical industry
The effect of Sida acuta on bacterial enzymes in azoxymethane-induced experimental colon cancer
Premature ageing in children: a rare genetic disorder called progeria.
Stress, Depression & Gut Microbiota: The Gut-Brain Axis Regulation
Zinc oxide nanoparticles and antibiotics mediated combinatorial approach to enhance antibacterial potential
Quality of life and associated factors among students in Jambi Province, Indonesia
Novel method for simultaneous determination of spiramycin and metronidazole in pharmaceutical dosage form by UV-visible absorption spectrophotometry
The Influence of Physicians Social Capital on Patients Satisfaction
1234
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Rationale for sublingual allergen-specific immunotherapy in immunocompromised patients

Author: FATIMA IRSALIEVA, ILMIRA RAZIKOVA, ZAYNITDIN KAMALOV, NAZIFA DUSTBABAYEVA, KUTBIDDIN NIZAMOV
Abstract: The dynamics of immunological status parameters was studied in 62 patients with persevering allergic rhinitis (PAR) who received a full course of allergen-specific immunotherapy (ASIT). Monitoring of immunological parameters level was carried out before immunocorrective therapy and after the ASIT course. The effectiveness of ASIT in patients with ATS is characterized by a high baseline immunological parameters CD3+; CD4+; CD8+ and IgG and changes in blood concentration IL-4, IL-6, IL-8 at the early stages of treatment.
Keyword: lymphocytes, immunocompetent cells, allergen-specific immunotherapy, persistent allergic rhinitis, cytokines, interleukines
DOI: https://doi.org/10.31838/ijpr/2020.12.02.0032
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free